D-0370-2022 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- January 19, 2022
- Initiation Date
- December 31, 2021
- Termination Date
- June 4, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,400 cartons
Product Description
MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 16714-090-01, packaged in cartons.
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Methylprednisolone, TN Norepinephrine BItartrate - MS, OH
Code Information
Lot # 100022393, exp 09/2022